Global Drug Discovery Services Market Growth & Innovations Studied for the Period 2017-2026

Fact.MR Fact.MR

Dublin 2, Ireland, 2018-Jun-22 — /EPR Network/ — The market for drug discovery services is set to gain staggering growth, as a novel research study presented by Fact. MR’s research experts projects an astounding 8.9% CAGR through the year 2017-26. The research report titled, “Drug Discovery Services Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” is a comprehensive and valuable source of information and analysis on global market. Covering key industry developments and market opportunity plan during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360 view on current and future market prospects.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=375

The report compiled by Fact.MR expects the global drug discovery services market is to witness robust growth, registering CAGR of 8.9% during 2017-2026. By the end of 2026, the global drug discovery services market is projected to reach US$ 16,800.1 million revenue. Increasing prevalence of chronic diseases and new diseases is driving the drug discovery services. Also, new technologies supporting drug discovery methods and techniques are evolving at a significant phase. Following are insight on how the global drug discovery services market will perform in the near future.

6 Key Insights on Global Drug Discovery Services Market

1. North America is likely to remain dominant in the global drug discovery services market throughout the forecast period 2017-2026. Presence of leading pharmaceutical companies in the region is one of the factors driving the growth of drug discovery services in North America.

2. Asia Pacific Excluding Japan (APEJ) is also anticipated to witness significant growth during 2017-2026. India and China are slowly becoming preferred locations for drug discovery outsourcing due to the technological capabilities developed. Fewer regulations and low manufacturing costs are also fueling the growth in APEJ region.

3. Hit-To-Lead identification is likely to be the most preferred process in the global drug discovery services market. By the end of 2026, hit-to-lead identification is projected to reach nearly US$ 7,000 million revenue.

4. By drug discovery service type, medicinal chemistry is likely to witness the significant growth. Towards the end of 2026, medicinal chemistry is projected to surpass US$ 6,000 million revenue.

5. Small molecules are anticipated to be the largest drug type in the global drug discovery service market. Small molecules are projected to create an incremental opportunity of more than US$ 5,800 million between 2017 and 2026.

6. On the basis of therapeutic area, highest growth is expected to be seen in oncology. Oncology is projected to reach nearly US$ 7,000 million revenue towards the end of 2026.

Medicinal Chemistry to be the Largest Type of Drug Discovery Services

Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.

Browse Full Report with TOC- https://www.factmr.com/report/375/drug-discovery-services-market

Oncology to Hold Largest Revenue Share in the Therapeutic Area

By therapeutic area, oncology is likely to emerge as the largest segment throughout the forecast period. Towards 2026 end, oncology is estimated to exceed US$ 6,900 million revenue. Increasing number of people suffering from cancer is resulting in the high demand for cancer therapies. Hence, oncology is anticipated to experience a significant growth in the coming years.

Table of Content:

1. Global Economic Outlook

2. Global Drug Discovery Services Market – Executive Summary

3. Global Drug Discovery Services Market Overview
3.1. Introduction
3.1.1. Global Drug Discovery Services Market Taxonomy
3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis
3.7. Product Life Cycle Analysis

4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026 
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
4.1.1. Target Selection Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region

Continued….

Buy this Report- https://www.factmr.com/checkout/375/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us on LinkedIn: https://www.linkedin.com/company/factmr/

Matched content

Editor’s pick

Express Press Release Distribution